Fondazione Telethon Ets

Where the EU money came from

Funding by EU programme. Amounts are Fondazione Telethon Ets's own share of each project, not the project's full budget.

Projects

69 EU-funded projects, newest first. Fondazione Telethon Ets led 35 of them as coordinator. Each links to the official record.

• STEM-SAFECoordinator

  Translating a Multi-Organ NAM into an Industrial Standard for Safety Assessment of Hematopoietic Stem Cell-Based Gene Therapies

  Horizon Europe · 2026–2027 · Project on CORDIS ↗

  €300ktheir share
• LEAD-ERCoordinator

  Leading small molecules for the selective protein clearance in ER disorders

  Horizon Europe · 2026–2028 · Project on CORDIS ↗

  €150ktheir share
• BEYONDCoordinator

  Broadening Expertise for YOung Researchers iN aDvanced Cell & Gene Therapies

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €5.9Mtheir share
• DIMERCIRCUITSCoordinator

  Engineering Synthetic Gene Circuits through Competitive Dimerization.

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €2.5Mtheir share
• RAREFINDCoordinator

  International Training for Doctoral Research on Advanced Gene and Cell Therapies

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €2.6Mtheir share
• NextGeneTxCoordinator

  Next generation versatile and effective AAV-mediated large gene delivery

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €1.5Mtheir share
• MENTORPartner

  Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €259ktheir share
• ERDERAPartner

  EUROPEAN RARE DISEASES RESEARCH ALLIANCE

  Horizon Europe · 2024–2031 · Project on CORDIS ↗

  €1.4Mtheir share
• ProgRetPartner

  European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €259ktheir share
• JOIN4ATMPPartner

  MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT

  Horizon Europe · 2024–2026 · Project on CORDIS ↗

  €150ktheir share
• EXPEDITECoordinator

  EXPanding AAV gene therapy by EDITing

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €2.5Mtheir share
• EP PerMedPartner

  European Partnership for Personalised Medicine

  Horizon Europe · 2023–2033 · Project on CORDIS ↗

  €55ktheir share
• INCANTARCoordinator

  TARGETING INHERITED CANCER SYNDROMES

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €2.5Mtheir share
• IMMUTOLCoordinator

  ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €1.3Mtheir share
• RETORNAPartner

  Targeting RNA as an approach for treating retinal disease

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €259ktheir share
• AUTO-SELECTPartner

  Dissect cargo selectivity in autophagy

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €1.4Mtheir share
• Re-MENDPartner

  Building REsilience against MEntal illness during ENDocrine-sensitive life stages

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €594ktheir share
• X-PANDAssociated partner

  Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

  Horizon Europe · 2022–2027 · Project on CORDIS ↗
• AAVolutionCoordinator

  Next-generation AAV vectors for liver-directed gene therapy

  Horizon Europe · 2022–2027 · Project on CORDIS ↗

  €1.4Mtheir share
• RE-STORECoordinator

  Pharmacological restoration of selective autophagy for the treatment of skeletal disorders

  Horizon 2020 · 2021–2022 · Project on CORDIS ↗

  €120ktheir share
• IC2PerMedPartner

  Integrating China in the International Consortium for Personalised Medicine

  Horizon 2020 · 2020–2023 · Project on CORDIS ↗

  €251ktheir share
• inSightPartner

  Moving a novel gene therapy paradigm to treat blindness to the market

  Horizon 2020 · 2019–2021 · Project on CORDIS ↗

  €42ktheir share
• RESTOREPartner

  RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

  Horizon 2020 · 2019–2020 · Project on CORDIS ↗

  €53ktheir share
• EJP RDPartner

  European Joint Programme on Rare Diseases

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  €1.0Mtheir share
• UPGRADECoordinator

  Unlocking Precision Gene Therapy

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  €5.0Mtheir share
• EASY-IPSCoordinator

  a rapid and efficient method for generation of iPSC

  Horizon 2020 · 2019–2021 · Project on CORDIS ↗

  €150ktheir share
• LYSOCILPartner

  Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies

  Horizon 2020 · 2018–2022 · Project on CORDIS ↗

  €183ktheir share
• StarTPartner

  European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €523ktheir share
• EpiTFebCoordinator

  Deciphering the Transcriptional Logic of TFEB activation in cell identity and cancer

  Horizon 2020 · 2018–2020 · Project on CORDIS ↗

  €180ktheir share
• CellKarmaCoordinator

  Dissecting the regulatory logic of cell fate reprogramming through integrative and single cell genomics

  Horizon 2020 · 2018–2024 · Project on CORDIS ↗

  €1.5Mtheir share
• UshTherCoordinator

  Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €1.8Mtheir share
• COSY-BIOCoordinator

  Control Engineering of Biological Systems for Reliable Synthetic Biology Applications

  Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  €556ktheir share
• GeneVisionCoordinator

  Developing a cure for retinitis pigmentosa due to Usher syndrome

  Horizon 2020 · 2017–2018 · Project on CORDIS ↗

  €150ktheir share
• LysoModPartner

  Genetic and Small Molecule Modifiers of Lysosomal Function

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗
• EYEGETCoordinator

  Gene therapy of inherited retinal diseases

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €2.4Mtheir share
• BONEPHAGYCoordinator

  Defining the role of the FGF – autophagy axis in bone physiology

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €1.6Mtheir share
• LYSOSOMICSCoordinator

  Functional Genomics of the Lysosome

  Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  €2.4Mtheir share
• REBuILDCoordinator

  Exploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseases

  Horizon 2020 · 2016–2018 · Project on CORDIS ↗

  €180ktheir share
• INCIPITPartner

  INnovative Life sCIence Phd Programme in South ITaly

  Horizon 2020 · 2016–2021 · Project on CORDIS ↗
• BATCurePartner

  Developing new therapies for Batten disease

  Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  €566ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 12 shared projects
• Eberhard Karls Universitaet TuebingenGermany · 10 shared projects
• Universita Degli Studi di Napoli Federico IiItaly · 10 shared projects
• Stichting Radboud UniversiteitNetherlands · 8 shared projects
• European Molecular Biology LaboratoryGermany · 8 shared projects
• The University of ManchesterUnited Kingdom · 6 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 6 shared projects
• Academisch Ziekenhuis LeidenNetherlands · 6 shared projects
• Fundacio Centre de Regulacio GenomicaSpain · 6 shared projects
• Universita Degli Studi Della Campania Luigi VanvitelliItaly · 6 shared projects
• Innovavector SRLItaly · 6 shared projects
• Next Generation Diagnostic SRLItaly · 6 shared projects
• Katholieke Universiteit LeuvenBelgium · 5 shared projects
• Uppsala UniversitetSweden · 5 shared projects
• Charite - Universitaetsmedizin BerlinGermany · 5 shared projects
• University College LondonUnited Kingdom · 5 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• alzheimer
• amyotrophic lateral sclerosis
• arteriosclerosis
• artificial intelligence
• autoimmune diseases
• bacteriology
• basic medicine
• biomolecules
• cell biology
• cell polarity
• cells technologies
• chromosomes